Previous close | 25.30 |
Open | 25.25 |
Bid | 25.30 x 100 |
Ask | 25.40 x 200 |
Day's range | 25.25 - 25.56 |
52-week range | 21.60 - 28.82 |
Volume | |
Avg. volume | 78,003 |
Market cap | 424.141M |
Beta (5Y monthly) | 1.31 |
PE ratio (TTM) | 16.68 |
EPS (TTM) | 1.52 |
Earnings date | 01 Aug 2024 |
Forward dividend & yield | 1.80 (7.10%) |
Ex-dividend date | 22 Jul 2024 |
1y target est | 28.50 |
RMR Group (NASDAQ:RMR) has had a great run on the share market with its stock up by a significant 12% over the last...
Key Insights Using the 2 Stage Free Cash Flow to Equity, RMR Group fair value estimate is US$29.63 With US$24.63 share...
NEWTON, Mass., August 19, 2024--The RMR Group (Nasdaq: RMR) today announced the early renewal of the Vertex Pharmaceuticals Incorporated ("Vertex") lease for 1.1 million square feet of office and laboratory space at 50 Northern Avenue and 11 Fan Pier Boulevard in Boston, Massachusetts. Vertex’s existing lease, which expires in December 2028, was extended for approximately 15 years, through June 2044.